Wells Fargo & Company Guardant Health, Inc. Put Options Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
Put Options
1 transactions
Others Institutions Holding GH
# of Institutions
315Shares Held
110MCall Options Held
2.51MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA11.4MShares$377 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11MShares$363 Million0.01% of portfolio
-
Baillie Gifford & CO6.09MShares$201 Million0.14% of portfolio
-
Deep Track Capital, LP Greenwich, CT6MShares$198 Million4.09% of portfolio
-
Cadian Capital Management, LP New York, NY5.79MShares$191 Million4.28% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $3.37B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...